Name: Sarah Johnson

Email: sarah.johnson@example.com

Age: 45

Sex: Female

Ethnic Group: White â€“ English, Welsh, Scottish, Northern Irish or British

Location: Manchester

Postcode: M1 1AA

NHS Number: 123 456 7890

MRN: MAN-456789

Vitals & Anthropometrics

Height (cm): 165

Weight (kg): 92

BMI: 33.8

Weight Date: 2025-01-20

Cardiometabolic

ASCVD: Yes

HTN: Yes (on treatment)

Dyslipidaemia: Yes

T2DM: Yes

Prediabetes: No

Diabetes Type: Type 2

HbA1c (%): 7.2

HbA1c Date: 2024-12-15

Baseline Fasting Glucose: 8.1 mmol/L

Random Glucose: 12.5 mmol/L

Lipid Profile

Total Cholesterol: 6.8 mmol/L

HDL: 1.0 mmol/L

LDL: 4.5 mmol/L

Triglycerides: 2.9 mmol/L

Lipid Date: 2024-12-15

Lipid Treatment: Atorvastatin 40mg daily

Sleep & Respiratory

OSA: Moderate

Sleep Studies: Yes - Polysomnography, AHI 22

CPAP: Yes

Asthma: No

Pulmonary HTN: No

Cardiac

Hypertension: Yes

IHD: Yes

Heart Failure: No

CVD: Yes

DVT: No

PE: No

GI & Renal

GORD: Yes

CKD: Stage 3a

Kidney Stones: No

MASLD: Yes (confirmed on ultrasound)

Endocrine & Reproductive

Thyroid Disorder: Hypothyroidism

Infertility: No

PCOS: No

IIH: No

Neurological

Epilepsy: No

FND: No

Psychiatric

Anxiety: Moderate

Depression: Yes

Bipolar: No

Emotional Eating: Yes

Schizoaffective: No

Musculoskeletal & Mobility

OA Knee: Yes

OA Hip: No

Limited Mobility: Yes

Lymphoedema: No

Cancer

Cancer: No

Bariatric History

Gastric Band: No

Sleeve: No

Bypass: No

Balloon: No

Medications

Antihypertensive Meds: Lisinopril 10mg daily, Amlodipine 5mg daily

Lipid Treatment: Atorvastatin 40mg daily

Diabetes Medications: Metformin 1000mg twice daily, Gliclazide 80mg twice daily

Other Medications: Levothyroxine 75mcg daily, Sertraline 100mg daily

Other

Comorbidities: Type 2 Diabetes Mellitus, Hypertension, Dyslipidaemia, ASCVD, Ischaemic Heart Disease, Cerebrovascular Disease, Obstructive Sleep Apnea, MASLD, GORD, Hypothyroidism, Anxiety, Depression, Emotional Eating, Osteoarthritis Knee, Limited Mobility

Total Qualifying Comorbidities: 15

Clinical Notes

Patient presents with multiple cardiometabolic risk factors. Well-controlled diabetes on dual therapy. Hypertension managed with ACE inhibitor and calcium channel blocker. Established cardiovascular disease with previous MI in 2022. Moderate OSA well-managed with CPAP compliance >90%. MASLD confirmed on imaging. Depression and anxiety managed with SSRI. Knee osteoarthritis affecting mobility. Regular monitoring of renal function required due to CKD Stage 3a. Patient counselled on lifestyle modifications including weight management, dietary changes, and increased physical activity within mobility limitations.

Last Visit

2025-01-20
